BioLineRx Announces Initiation of Phase 2b Trial for Novel AML Consolidation Treatment
Phase 2b study, as consolidation treatment for AML patients responding to standard induction treatment, will enroll up to 194 patients, randomized
in 1:1 ratio, at up to 25 sites in Germany